US Stock MarketDetailed Quotes

SABSW SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM)

Watchlist
  • 0.0500
  • 0.00000.00%
Trading Jul 18 10:28 ET
0Market Cap0.00P/E (TTM)

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
-1,280.73%-23.46M
68.12%-1.56M
-308.53%-7.92M
30.35%-4.45M
Net income from continuing operations
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
-74.24%-7.08M
-62.36%-4.78M
Operating gains losses
-6,521.24%-5.47M
146.74%4.87M
13,183.43%4.79M
75.08%-195.47K
120.66%357.52K
98.95%-82.59K
-399.28%-10.42M
-100.88%-36.6K
---784.48K
-31,424.78%-1.73M
Depreciation and amortization
114.99%1.98M
13.77%3.75M
2.26%944.4K
8.30%985.45K
14.25%892.27K
36.27%923.17K
99.07%3.29M
39.68%923.52K
119.24%909.91K
160.20%781K
Other non cash items
-189.80%-83.99K
11,623.32%3.71M
--3.57M
--0
--50K
--93.53K
---32.21K
----
----
----
Change In working capital
-165.88%-2.77M
1,079.15%2.33M
-108.84%-427.41K
3.33%-1.49M
-94.75%37.13K
199.44%4.21M
-102.03%-237.58K
299.83%4.84M
-123.56%-1.55M
116.95%707.17K
-Change in receivables
-104.03%-193.23K
126.42%5.56M
--0
110.86%361.74K
-81.53%401.39K
226.95%4.79M
-80.46%2.45M
235.32%7.39M
-148.28%-3.33M
139.41%2.17M
-Change in prepaid assets
-190.79%-289.54K
-177.62%-523.61K
-155.56%-1.41M
-74.44%230.56K
-50.14%338.79K
189.93%318.9K
153.61%674.55K
65.25%-552.46K
274.75%902.12K
-19.64%679.5K
-Change in payables and accrued expense
66.30%-1.34M
-33.04%-4.42M
161.02%1.3M
-203.00%-947.76K
62.41%-799.85K
-29,207.33%-3.97M
-843.79%-3.32M
-445.79%-2.13M
372.32%920.19K
-513.12%-2.13M
-Change in other current assets
-108.29%-10.4K
624.72%387.3K
-105.88%-7.56K
426.64%128.11K
885.63%141.22K
794.31%125.53K
183.99%53.44K
828.78%128.72K
-254.71%-39.22K
-0.72%-17.98K
-Change in other working capital
-132.14%-944.58K
1,422.41%1.32M
---305.01K
---1.27M
---44.42K
3,039.20%2.94M
---100K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
-1,280.73%-23.46M
68.12%-1.56M
-308.53%-7.92M
30.35%-4.45M
Investing cash flow
Cash flow from continuing investing activities
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
97.57%-78.5K
82.31%-612.83K
Net PPE purchase and sale
-505.98%-129.07K
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
97.57%-78.5K
82.31%-612.83K
Net investment purchase and sale
---31.23M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
97.57%-78.5K
82.31%-612.83K
Financing cash flow
Cash flow from continuing financing activities
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
-97.07%1.05M
-76.72%8.39M
-460.39%-287.08K
-1,481.38%-731.04K
Net issuance payments of debt
31.59%-247.44K
67.05%-390.45K
-32.39%477.76K
50.28%-142.74K
54.54%-363.79K
55.04%-361.68K
-176.73%-1.19M
-58.12%706.69K
-460.39%-287.08K
-1,630.95%-800.18K
Net common stock issuance
----
--0
--0
--0
----
----
--2.16M
--7.68M
--0
--0
Net preferred stock issuance
----
--7.5M
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
980.00%20.41K
77,414.37%59.66M
5,965,926,300.00%59.66M
242,900.00%2.43K
--0
-75.86%1.89K
1,040.31%76.97K
-100.01%-1
--1
--69.14K
Net other financing activities
---167.39K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
-97.07%1.05M
-76.72%8.39M
-460.39%-287.08K
-1,481.38%-731.04K
Net cash flow
Beginning cash position
275.93%56.57M
-61.95%15.05M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
-61.95%15.05M
213.59%39.55M
-22.50%8.33M
62.39%16.62M
11.33%22.41M
Current changes in cash
-2,039.29%-42.5M
269.40%41.5M
706.03%54.12M
35.43%-5.35M
8.74%-5.29M
88.41%-1.99M
-190.95%-24.5M
-76.68%6.71M
-1,699.02%-8.28M
41.47%-5.79M
Effect of exchange rate changes
---28.27K
--18.14K
----
----
----
--0
--0
----
----
----
End cash Position
7.46%14.03M
275.93%56.57M
275.93%56.57M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
-61.95%15.05M
-61.95%15.05M
-22.50%8.33M
62.39%16.62M
Free cash flow
-568.65%-10.88M
1.21%-25.32M
-707.91%-13.51M
34.31%-5.25M
2.75%-4.92M
85.07%-1.63M
-186.11%-25.63M
76.90%-1.67M
-1,504.71%-8M
48.62%-5.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -569.48%-10.75M-7.08%-25.12M-764.73%-13.45M34.74%-5.17M-10.14%-4.9M83.16%-1.61M-1,280.73%-23.46M68.12%-1.56M-308.53%-7.92M30.35%-4.45M
Net income from continuing operations 31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M-9.31%-18.74M31.83%-7.87M-74.24%-7.08M-62.36%-4.78M
Operating gains losses -6,521.24%-5.47M146.74%4.87M13,183.43%4.79M75.08%-195.47K120.66%357.52K98.95%-82.59K-399.28%-10.42M-100.88%-36.6K---784.48K-31,424.78%-1.73M
Depreciation and amortization 114.99%1.98M13.77%3.75M2.26%944.4K8.30%985.45K14.25%892.27K36.27%923.17K99.07%3.29M39.68%923.52K119.24%909.91K160.20%781K
Other non cash items -189.80%-83.99K11,623.32%3.71M--3.57M--0--50K--93.53K---32.21K------------
Change In working capital -165.88%-2.77M1,079.15%2.33M-108.84%-427.41K3.33%-1.49M-94.75%37.13K199.44%4.21M-102.03%-237.58K299.83%4.84M-123.56%-1.55M116.95%707.17K
-Change in receivables -104.03%-193.23K126.42%5.56M--0110.86%361.74K-81.53%401.39K226.95%4.79M-80.46%2.45M235.32%7.39M-148.28%-3.33M139.41%2.17M
-Change in prepaid assets -190.79%-289.54K-177.62%-523.61K-155.56%-1.41M-74.44%230.56K-50.14%338.79K189.93%318.9K153.61%674.55K65.25%-552.46K274.75%902.12K-19.64%679.5K
-Change in payables and accrued expense 66.30%-1.34M-33.04%-4.42M161.02%1.3M-203.00%-947.76K62.41%-799.85K-29,207.33%-3.97M-843.79%-3.32M-445.79%-2.13M372.32%920.19K-513.12%-2.13M
-Change in other current assets -108.29%-10.4K624.72%387.3K-105.88%-7.56K426.64%128.11K885.63%141.22K794.31%125.53K183.99%53.44K828.78%128.72K-254.71%-39.22K-0.72%-17.98K
-Change in other working capital -132.14%-944.58K1,422.41%1.32M---305.01K---1.27M---44.42K3,039.20%2.94M---100K--0--0--0
Cash from discontinued investing activities
Operating cash flow -569.48%-10.75M-7.08%-25.12M-764.73%-13.45M34.74%-5.17M-10.14%-4.9M83.16%-1.61M-1,280.73%-23.46M68.12%-1.56M-308.53%-7.92M30.35%-4.45M
Investing cash flow
Cash flow from continuing investing activities -147,126.32%-31.36M92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K80.90%-2.09M95.01%-117.75K97.57%-78.5K82.31%-612.83K
Net PPE purchase and sale -505.98%-129.07K92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K80.90%-2.09M95.01%-117.75K97.57%-78.5K82.31%-612.83K
Net investment purchase and sale ---31.23M------------------0----------------
Cash from discontinued investing activities
Investing cash flow -147,126.32%-31.36M92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K80.90%-2.09M95.01%-117.75K97.57%-78.5K82.31%-612.83K
Financing cash flow
Cash flow from continuing financing activities -9.62%-394.42K6,250.81%66.77M706.40%67.64M51.13%-140.31K50.24%-363.79K94.31%-359.79K-97.07%1.05M-76.72%8.39M-460.39%-287.08K-1,481.38%-731.04K
Net issuance payments of debt 31.59%-247.44K67.05%-390.45K-32.39%477.76K50.28%-142.74K54.54%-363.79K55.04%-361.68K-176.73%-1.19M-58.12%706.69K-460.39%-287.08K-1,630.95%-800.18K
Net common stock issuance ------0--0--0----------2.16M--7.68M--0--0
Net preferred stock issuance ------7.5M------------------0------------
Proceeds from stock option exercised by employees 980.00%20.41K77,414.37%59.66M5,965,926,300.00%59.66M242,900.00%2.43K--0-75.86%1.89K1,040.31%76.97K-100.01%-1--1--69.14K
Net other financing activities ---167.39K------------------------------------
Cash from discontinued financing activities
Financing cash flow -9.62%-394.42K6,250.81%66.77M706.40%67.64M51.13%-140.31K50.24%-363.79K94.31%-359.79K-97.07%1.05M-76.72%8.39M-460.39%-287.08K-1,481.38%-731.04K
Net cash flow
Beginning cash position 275.93%56.57M-61.95%15.05M-70.89%2.43M-53.21%7.77M-41.72%13.06M-61.95%15.05M213.59%39.55M-22.50%8.33M62.39%16.62M11.33%22.41M
Current changes in cash -2,039.29%-42.5M269.40%41.5M706.03%54.12M35.43%-5.35M8.74%-5.29M88.41%-1.99M-190.95%-24.5M-76.68%6.71M-1,699.02%-8.28M41.47%-5.79M
Effect of exchange rate changes ---28.27K--18.14K--------------0--0------------
End cash Position 7.46%14.03M275.93%56.57M275.93%56.57M-70.89%2.43M-53.21%7.77M-41.72%13.06M-61.95%15.05M-61.95%15.05M-22.50%8.33M62.39%16.62M
Free cash flow -568.65%-10.88M1.21%-25.32M-707.91%-13.51M34.31%-5.25M2.75%-4.92M85.07%-1.63M-186.11%-25.63M76.90%-1.67M-1,504.71%-8M48.62%-5.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg